Clinico-demographic profile of children with neurocysticercosis and risk factors for persistent seizures
DOI:
https://doi.org/10.18203/2349-3291.ijcp20230423Keywords:
Neurocysticercosis, Epilepsy, Persistent seizuresAbstract
Background: Neurocysticercosis is one of the common cause of acquired epilepsy in childhood. The objective of this study was to study the clinic-demographic profile of children having Neurocysticercosis and to evaluate the potential risk factors for persistent seizures.
Methods: A prospective observational study was conducted after recruiting 30 children with neurocysticercosis. After detailed history and clinical examination, the neuroimaging findings were studied. Patients were started on standard anti-helmenthic and antiepileptic therapy. A regular follow up was taken with regard seizure recurrence. A neuroimaging was repeated at 6 moths follow up.
Results: Among 30 children with neurocysticercosis who presented with first seizure due to neurocysticercosis, focal seizure was the commonest (63.3%) presentation and 23.3% of these presented with status epilepticus. Out of 30 cases, 7 (23.3%) patients had seizure recurrence on follow up. Patients presenting with status epilepticus, neuroimaging showing larger lesions (size more than 10 mm), multiple number of lesions and persistent presence of lesion on the CT scan at a follow up of 6 months were the factors found to have significant positive association with recurrence of seizures on follow up.
Conclusions: There are potential clinical and radiological risk factors which are associated with the recurrence or persistence of seizures in patients with neurocysticercosis.
References
Rajshekhar V. Neurocysticercosis: Diagnostic problems and current therapeutic strategies. Indian J Med Res. 2016;144(3):319-26.
Relationship between epilepsy and tropical diseases. Commission on Tropical Diseases of the International League Against Epilepsy. Epilepsia. 1994;35(1):89-93.
Singhi P, Ray M, Singhi S, Khandelwal N. Clinical spectrum of 500 children with neurocysticercosis and response to albendazole therapy. J Child Neurol. 2000;15(4):207-13.
Escobar A. The pathology of neurocysticercosis. In: Palacios E, Rodriguez-Carbajal J, Taveras JM, eds. Cysticercosis of Cenntral Nervous System. USA: Charles Thomas; 1983: 27-54.
Brutto OH. Neurocysticercosis: new thoughts on controversial issues. Curr Opin Neurol. 2013;26(3):289-94.
Nash TE, Pretell EJ, Lescano AG, Bustos JA, Gilman RH, Gonzalez AE, et al. Perilesional brain oedema and seizure activity in patients with calcified neurocysticercosis: a prospective cohort and nested case-control study. Lancet Neurol. 2008;7(12):1099-105.
Talukdar B, Saxena A, Popli VK, Choudhury V. Neurocysticercosis in children: clinical characteristics and outcome. Ann Trop Paediatr. 2002;22(4):333-9.
Baranwal AK, Singhi PD, Singhi SC, Khandelwal N. Seizure recurrence in children with focal seizures and single small enhancing computed tomographic lesions: prognostic factors on long-term follow-up. J Child Neurol. 2001;16(6):443-5.
Goel D, Mittal M, Bansal KK, Singhal A. Natural history of solitary cerebral cysticercosis cases after albendazole therapy: a longitudinal follow-up study from India. Acta Neurol Scand. 2010;121(3):204-8.
García HH, Evans CA, Nash TE, Takayanagui OM, White AC, Botero D, et al. Current consensus guidelines for treatment of neurocysticercosis. Clin Microbiol Rev. 2002;15(4):747-56.
Kumar A, Mandal A, Sinha S, Singh A, Das RR. Prevalence, Response to Cysticidal Therapy, and Risk Factors for Persistent Seizure in Indian Children with Neurocysticercosis. Int J Pediatr. 2017;2017:8983958.
Gupta MM, Chaudhary N, Pathak S, Agrawal N, Yadav J, Shrestha S, et al. Neurocysticercosis in Children with Seizures: A Cross-Sectional Study. Int J Pediatr. 2018;2018:1030878.
Singh AK, Garg RK, Rizvi I, Malhotra HS, Kumar N, Gupta RK. Clinical and neuroimaging predictors of seizure recurrence in solitary calcified neurocysticercosis: A prospective observational study. Epilepsy Res. 2017;137:78-83.
Rao KS, Adhikari S, Gauchan E, Sathian B, Basnet S, Tiwari PK, et al. Time trend of neurocysticercosis in children with seizures in a tertiary hospital of western Nepal. PLoS Negl Trop Dis. 2017;11(5):e0005605.
Carpio A, Hauser WA. Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology. 2002;59(11):1730-4.
Goel D, Mittal M, Bansal KK, Singhal A. Natural history of solitary cerebral cysticercosis cases after albendazole therapy: a longitudinal follow-up study from India. Acta Neurol Scand. 2010;121(3):204-8.
